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REVIEW ARTICLE

ROLE OF RADIOSURGERY IN ARTERIOVENOUS MALFORMATIONS
Syed Ijlal Ahmed, Gohar Javed*, Saher Naseeb Uneeb**, Syeda Beenish Bareeqa***,
Manaal Haider†, Syeda Sana Samar††, Armghan Haider Ans†††, Muhammad Tayyab SheraΔ
Abbasi Shaheed Hospital, Karachi, *Aga Khan University Hospital, Karachi, **Liaquat National Medical College, Karachi, ***Jinnah
Medical and Dental College, Karachi, †Bahria Medical University, Karachi, ††Jinnah Sindh Medical University, Karachi, †††Services
Institute of Medical Science, Lahore, ΔKing Edward Medical University, Lahore-Pakistan

Background: Intracranial arteriovenous malformations (AVMs) consist of an abnormal nidus of
blood vessels that shunt blood directly from an artery to a vein and thereby bypass an intervening
capillary bed. AVMs may be found as an incidental finding. They may be associated with
intracranial haemorrhage, seizures, headaches or neurological deficits. There are different
treatment options for AVM. These include observation, microsurgery, Stereotactic radio surgery
(SRS), endovascular embolization and intensity modulated radiotherapy (IMRT). Method: Data
was collected using searching engines like Pubmed, Google scholar, Embase, Cinahl and Medline.
MeSH and Non-MeSH terms were used like Arterio-venous malformations, microsurgery,
endovascular embolization. Results: Multiple interventional radiosurgical techniques have been
introduced in recent years. The most effective and least risk-associated methods are Stereotactic
radiosurgery, Microsurgery, Embolization and Intensity modulated radiotherapy (IMRT).
However, the outcome of such treatment modalities depends upon Site of malformation, grade of
AVM, patient’s age/gender, dose and volume of radiosurgery. Digital substraction angiography
(DSA) and MR angiography (MRA) are most suitable methods for the follow-up of AVMs.
Conclusion: Stereotactic radiosurgery is the most suitable technique for AVMs considering the
good prognosis and the risks associated with this procedure. However, large AVMs require multidisciplinary approach for better results.
Keywords: Arterio-venous malformations; Stereotactic radio-surgery, Microsurgery;
Endovascular embolization
Citation: Ahmed SI, Javed G, Uneeb SN, Bareeqa SB, Haider M, Samar SS, et al. Role of Radiosurgery in Arteriovenous
malformations; A Comprehensive Literature review. J Ayub Med Coll Abbottabad 2018;30(3):449–57.

INTRODUCTION
Intracranial arteriovenous malformations (AVMs)
consist of an abnormal nidus of blood vessels that
shunt blood directly from an artery to a vein and
thereby bypass an intervening capillary bed.1 They
are intraparenchymal collection of dilated arteries
and veins which lack normal vascular organization at
the sub arteriolar level as well as a normal capillary
bed.2 The incidence of AVM is estimated to be 1.12–
1.34 per 100,000 person/years.3 AVMs may be found
as an incidental finding. They may be associated with
intracranial haemorrhage, seizures, headaches or
neurological deficits.
There are different treatment options for
AVM. These include observation, surgical removal
of AVM, stereotactic radio-surgery (SRS),
endovascular embolization4 and intensity modulated
radiotherapy (IMRT).
Gamma knife, x knife and charged particles
are included in types of SRS. SRS has a clinical
obliteration rate of 80%5 with no long term cognitive
effects6. The outcome of SRS was determined by a
number of factors. The success rate was increased
with smaller volume (up to 30 cm3)7, lower grade,
higher dose, and steeper dose gradient8.

Complications after SRS include haemorrhage,
seizures, delayed cysts and other adverse effects.
Complication risk was increased due to incomplete
obliteration of the lesion.9 Complication risk was
dependent on clinical history, previous AVM surgery
and previous radiation exposure. It was not
dependent on age or gender.10 The purpose of the
literature review was to compile all the previous
research done on this topic. Although there have been
previous reviews done, however, they are either
specific to a particular tumour size or a particular
type of radiosurgery. Since radiosurgery is a common
modality used in many centres it was essential to
compile all the different types of radio surgery and
the effect of this treatment modality with regards to
different tumour sizes and other factors that
determine treatment outcome. On the basis of this
literature review, stereotactic radio surgery was
considered a good treatment modality due to it being
a minimally invasive procedure with a high
obliteration rate and low complication risk. It was
considered as a good option for tumours that had
lesser volume but higher grade. However, for
tumours with greater volume and larger size a
multimodal approach can be considered such as
microsurgery combined with radiosurgery, combined
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embolization and radiosurgery and intensity
modulated radiotherapy. The latter being the
preferred choice in children with higher grade and
larger size of AVM.11
Radio-surgery is surgery using ionizing
radiation that precisely destroys targeted areas. In
SRS, stereotactic refers to a three-dimensional
coordinate system. This system relates the virtual
target seen in diagnostic images with the actual target
position. Among the many treatment options for
AVM, SRS has become one treatment modality.1,12–14
The purpose of our study is to discuss radio
surgery as a treatment modality for AVM and to
evaluate its outcome.
Types of SRS
There are different types of stereotactic radio surgery.
Among them are Gamma knife which uses photons,
linear accelerator (LINAC) which uses X-rays and
charged particles such as helium or protons.15 All
these types of radio surgery are in use and are equally
effective. The physical accuracy was comparable
between different radio surgical methods. Linear
accelerators are preferred for intermediate sized
lesions (5–25 cm3).16 However, Semwal et al in a
more recent study in 2012 published a retrospective
comparative study that suggested that gamma knife is
better than x knife (LINAC). Gamma knife having a
higher performance conformity index (PCI)
0.664±0.048 as compared to x knife 0.501±0.240 but
as the distance from the target increases x-knife
become a better option than gamma knife.17 Beams of
heavy charged particles, however, are preferred for
intracranial lesions15 as the complete obliteration rate
was 94% for smaller lesions, the clinical outcome
was excellent in 58% of patients and neurological
complications occurred in 12% of patients.
After irradiation, there is endothelial cell
proliferation, vessel wall thickening and closure of
vessel lumen leading to successful obliteration.18
Treatment modalities
1) SRS-Stereotactic radiosurgery is a minimally
invasive procedure and is considered as an
effective treatment. In 1992, Steiner et al.
published an interventional clinical study that
was done to assess the clinical outcome of
radio surgery; it suggested that the complete
obliteration rate of AVM was 79–95%.12 This
was in line with findings of 2 more articles
which determined the factors associated with
AVM radio surgery outcome. In 1998
Pollock et al published a multivariate analysis
that found that the AVM obliteration rate was
80%.1 Chang et al published an interventional
study in the year 2000 and stated that the
AVM obliteration rate was 78.9%.14 Besides
the obliteration rate a cohort study was done
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by Raghunath et al in 2016 to determine the
cognitive outcomes of radio surgery.2 This
study stated that there were no long-term
cognitive effects of this method as the
outcome rate involving nidus obliteration
with no new neurological deficits was found
to be 66.6% and in fact several years later
there was also improvement of memory after
treatment. The perseverative responses that is
the ability to repeat a particular phrase was
seen to decrease from a value of 26.5–18.2.
Set shifting that is the ability to
unconsciously shift from one task to another
was seen to improve in 11 out of 34 patients.
This study however mentioned that more
research is required to assess AVM
obliteration
and
its
effect
on
neuropsychological outcome because all
AVMs showed some response at 2 years
follow up and so effect of obliteration could
not be analysed.2 B. Shäuble et al in the year
2004 did a comparative cross-sectional study
on seizure outcome after radiosurgery and it
was found to improve with 78% patients
having an excellent outcome.19
2) Microsurgery- This treatment modality
can be used alone or in combination with
each other. Pikus et al published a
prospective analysis of 72 patients in 1998
and it suggested that microsurgery is better
than radio surgery for AVM of grade 1–3
according to the Spetzler Martin Grading.20
This was also confirmed by Lunsford et al.
who in 1991 published an interventional
study that stated that microsurgery is the most
effective method for AVM.21 Steiner et al in
1993 performed a comparative study that
discouraged the overuse of radiosurgery.22
However, Firlik et al. in 1998, in a technical
case report suggested that radiosurgery and
microsurgical resection should be combined
for grade 5 AVM.23 This had been
contraindicated previously by Steinberg et al.
in 1996 who in a clinical study stated that
resection becomes more difficult after radio
surgery but it went on to suggest that if radio
surgery is done several years before surgery
then it can be useful for large AVMs because
they might be untreatable if a single treatment
modality is used.24 A more recent
retrospective cohort study done by
Marciscano et a. which was published in the
year 2017 was done to assess the long-term
outcomes of repeat radio surgery. They
concluded that high grade AVM can be
treated with multistage radio surgery with
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complete obliteration rate being 38%.25 Robin
M. Starke et al in the year 2013 created the
Virginia
Radiosurgery
Scale
(VRS).
Although, the Spetzler-Martin Grading is the
most frequently used and quoted grading
system, however, its elements which include
size, venous drainage pattern and location are
not accurate predictors of outcome in those
who receive treatment with SRS. The VRS
with three elements which included history of
haemorrhage, AVM volume and AVM
location was found to be mathematically
more complex but in terms of accuracy it was
more superior to the Setzler Martin grading.26
3) Embolization- Mathis et al performed a
retrospective study that was published in the
year 1995. They found that geometry of the
equipment and dose limitation led to a fall in
the obliteration rate from 80% to 28% for
AVM with a volume greater than 10 cm3 and
a size greater than 2.7 cm treated with radio
surgery alone. AVM which were treated with
embolization and radiosurgery with size
greater than 3 cm were found to have an
obliteration rate of 50% with no permanent
neurological deficits. And hence they
concluded embolization before radiosurgery
was a better option for large AVMs.27
However, in the year 2007,
Watanabe et a. published a clinical trial that
suggested that radiosurgery alone is a better
treatment modality as embolization decreases
the obliteration rate. In the group that was
treated with radiosurgery and embolization
the obliteration rate was found to be 47%
while in those treated with radiosurgery alone
the obliteration rate was found to be 70%.28
This was found due to recanalization of
embolized AVM, difficult targeting and dose
reduction due to high density material that is
used.29
In a more recent retrospective study done in
2011 by Blackburn et al. it was found that that
the obliteration rate was higher in large AVMs
(greater than 3 cm) that were treated with a
combination of embolization and radiosurgery
being 81%.30
Xu et al in the year 2014 performed a metaanalysis that also confirmed that embolization
decreases the obliteration rate. The group that
received SRS and embolization (group 1) had
an obliteration rate of 41% (group 2). While
those who only underwent SRS the
obliteration rate was 59%. The haemorrhage
rate in group 1 was found to be 7.3% while
that in group 2 was found to be 5.6%.

Neurological deficits in group 1 were found to
be 3.3% while those in group 2 were found to
be 3.4%. However, statistically there was no
difference in the haemorrhage rate and in
occurrence
of
neurological
deficits.31
However, one of the limitations of the study
that was mentioned was that most of the cases
were retrospective and none of the studies had
a randomized design.
The material used for embolization also
plays a role in the obliteration rate as
particulate embolization may be found to have
a risk of recanalization of the nidus.27 Onyx
embolization has been found to be an
alternative. Xu et al performed a clinical trial
where instead of using the high-density
material, Onyx embolization was used to
reduce the size of AVM without significant
complication. Complete obliteration was found
in 18.6% of patients with large AVMs (greater
than 3 cm) and a volume reduction of 80.5%.
This study, however, had the limitation of not
having a large sample size and patients were
lost to follow-up.32
Hence with regards to embolization
there is some controversy, however, there is
general consensus that using embolization
before radiosurgery for large AVMs has a
beneficial outcome.
4) Intensity modulated radiotherapy
(IMRT) Another treatment modality could be
the use of IMRT. Optically guided technology
provides improved patient localization and
online monitoring of patient position during
treatment delivery, it allows for safe and
efficient delivery of intensity modulated
radiotherapy.33 A clinical study was done to
compare SRS with IMRT. It revealed that for a
single small target both SRS and IMRT have
comparable results. However, for AVM that
are larger (greater than 4 cm) and more
irregular IMRT seems to be more superior.34
With radiosurgery, the entire target was
covered by the 90.7% isodose line. The
maximum dose within the target was 1.02 G.
The coverage was 0.99. The homogeneity
index (HI) was 1.13 and the conformity index
was 4.1. With IMRT, the maximum dose
within the target was 1.25 Gy. The coverage
was 0.99. The HI was 1.25 and the CI was
2.57.34
Factors determining the outcome of SRS
The outcome of radio surgery was determined by a
number of factors. Small volume (less than 2 cm in
diameter), hemispheric AVM and single session
predict success after radio surgery with an AVM
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obliteration rate of 80%.1 This is in conjunction with
a meta-analysis and systemic review published in
2014 by Xu et al. and that suggested that treatment
failure occurred more frequently when AVM volume
was greater than 10mL, lower dose 50cGy was used,
there were multiple isocentres and previous
haemorrhage history.31 Ellis et al in 1996 in a
multivariate analysis looked at reasons for treatment
failure after radio surgery and found that 72 patients
attained angiographically confirmed cures after
radiosurgery and 36 were retreated after the initial
radio surgical treatment failed.35 L Dade Lunsford et
al. performed a clinical trial that was published in the
year 1991 and found that success and complication
risks are related to the AVM location and the volume
that needs to be treated. These complications
included 6.7% of patients developing neurological
deficits which were due to radiation induced injury,
intracranial haemorrhage occurred in 4.7% of
patients, however, post radio surgery seizure and
headache frequency was seen to improve, with
reduction of seizures in 51% of patients and headache
improvement in 75% of patients.21
A multivariate analysis published in 1999
that was performed by Miyawaki et al. to assess the
relationship of dose and volume to obliteration as
well as to complications found that obliteration rate
for volumes <4 mL was 67% and as volume
increased the obliteration rate decreased and
complication rate increased. There was also a greater
incidence of radiation necrosis.36 This is however in
contradiction to a previous study published in 1996
by Flickinger et al. which stated that obliteration rate
was related to minimum dose but it had no relation
with volume or maximum dose.37
A retrospective analysis published in 1995
by Yamamoto et al. was done to find out the
relationship between dose and volume. It revealed
that malformations up to 30 cm3 in volume could be
treated effectively with an acceptably low
complication rate using a dose of 16 Gy.3
In a multivariate analysis published in 1992
by Flickinger et al it was found that volume was the
only significant factor associated with the
development of imaging changes on MRI which
included new regions of increased T2 signal on
MRI.38
Pasquale Gallena et al performed a
retrospective study that was published in the year
1998, they found that that partial volume irradiation
shouldn’t be done and aim of treatment should be to
completely obliterate the nidus as this lead to an
increased risk of haemorrhage which was because of
the rise in the pressure gradient through the
malformations.39
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An inferential analysis done by Karlsson et al that
was published in 1997 stated that the probability of
obliteration of AVMs after gamma knife surgery is
related both to the lowest dose given to the AVMs and
the AVM volume which can be predicted by K
index.40 The obliteration rate was seen to increase as
the K value increased up to a value of 27.
Large AVMs are usually considered those
that are larger than 30 cm3.41 Treatment becomes
more difficult as size increase. There are many
treatment options for such a situation e.g. repeated
gamma radiation, stereotactic radio-surgery, staged
volume radio-surgery, hypo fractionated stereotactic
radiation (HSRT) and surgical excision. Yu et al did
a clinical review in 2010 where they found out that
repeated Gamma radiation should be considered as a
treatment option for large AVMs. Even though this
method had the disadvantage of taking longer but the
complication and obliteration rate were quite
acceptable. The overall obliteration rate was found to
be 34.1%, the approximate obliteration rate in 120
months was calculated to be 41.8%. Of 44 patients, 3
(6.8%) experienced haemorrhages after GKS, cysts
developed in 2 patients (4.5%), One patient (2.3%)
experienced a newly developed seizure and another
patient (2.3%) developed radiation necrosis.41 This is
in concurrence with a retrospective study done in
2009 that suggested that stereotactic radio-surgery is
a safe and effective option for large sized AVM.42
Prospective staged volume radio-surgery is also a
treatment option that can be utilized for cases where
no other therapy can be used.43
Xiao et al in 2009 published a retrospective
study that suggested that before single dose radio
surgery, HSRT can be given and it had the advantage
of not increasing the bleeding risk with the median
AVM volume decreasing to a value of 13.51 cm3.
But they also stated that future studies needed to be
done to confirm their results.44 This was in line with a
literature review published in 2012 by Wang et al.
that stated that rate of AVM obliteration utilizing
HSRT as a primary treatment was comparable with
that of radio-surgery.45 Reinard et al in 2015
published a clinical review on ‘Surgical management
of giant AVM’ and suggested that surgery could be
one of the treatment options since it caused complete
obliteration in 90% of patients. But since giant
AVMs have a high mortality rate a multimodal
treatment approach should be used.46
Friedman et al. in 2012 in a multi variate
analysis suggested that lower Spetzler- Martin grade,
higher dose and steeper dose gradient increased the
success rate.4 This was in accordance with a
multivariate analysis that treatment failure was
because of increasing AVM size, decreasing
treatment dose, and higher Spetzler Martin grade.
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There was also an important factor that needed to be
considered which was treating high grade AVM with
planned multi stage dose or single dose. An
interventional study done by Pollock et al published
in the year 2000 suggested that staged volume radio
surgery had the advantage of less radiation exposure
to the adjacent brain. However, it also mentioned that
further follow up will be required to find out if this
technique provides high obliteration rate.47 A more
recent article done to find long-term outcomes of
mutli-stage dosage in 2017 by Marciscano et al found
that this method achieves successful AVM
obliteration with acceptable adverse effect rates.25
This was in agreement with a retrospective study
done by Iyas et al and was published in 2017. It
suggested that volume staged stereo-static radiosurgery was a good treatment option for large AVMs.
There were no cases of post treatment haemorrhage
and this approach was found to decrease the nidus
size.48 The median AVM volume reduction was
found to be 87%.
A retrospective analysis was done by
Pollock et al. published in 1996 to find out the
reasons for incomplete obliteration. The most
frequent factor turned out to be incomplete
angiographic definition.49 This was also stated in a
previously mentioned article that observed some
errors in finding out AVM target shape and size.
These errors were attributed to inaccurate definition
of the nidus and because of incomplete stereoangiography.39 Rate of AVM obliteration depended
on marginal dose and problems in dose response
plateau were attributed to problems in target
definition.50
Outcome of radio-surgery was also
dependant on the location of the AVM. Brain AVMs
are classified into superficial and deep types.
Superficial AVMs are further divided into sulcal,
gyral, or mixed, while deep types that are relatively
rare are subdivided into subarachnoid, deep
parenchymal, plexal, and mixed types.51 In a
retrospective review done by Kurita et al. published
in the year 2000, it was stated that radio surgery is a
good treatment option for small deep parenchymal
brain stem AVMs.52 Ellis et al in 1996 in a
multivariate analysis showed that radiosurgery is also
a good treatment option for intracranial dural AV
fistulas.35 However if the AVM is located at a deeper
location it decreases the chance of radio-surgical
success. Pollock et al in 2004 published a clinical
study that was done for deeply located AVM
revealed that there is difficulty in treating patients
with deeply located AVMs and that most of them are
also poor candidates for surgical resection or
embolization.13 There was general consensus that
radiosurgery is a good treatment modality for deep

AVM however there was still some risk of latent
haemorrhage in incompletely obliterated nidus.52
Grade is also an important factor. A number
of articles suggest that microsurgery is preferred for
lower grade.20,21,26 Radio surgery with stereotactic
MR targeting and multiplanar dose planning can be
used for treatment of larger AVMs (30 cm3).53
In children, different treatment options are
considered. Capitanio et al in 2016, in a retrospective
review suggested that stereotactic radiosurgery (SRS)
at an optimum radiation dose of 18–25 Gy can be
used as a safe and effective method for AVM.54 This
is in agreement with a clinical study done by Yen et
al. in 2010 that states that gamma knife radiosurgery
at an optimum radiation dose of 21.9 Gy causes
reasonable obliteration of AVM with decreased
radiation induced adverse effects.55 Another clinical
article by Blamek et al in 2013 states that stereotactic
linac radiosurgery is an effective method for AVM in
children. However, follow up is required because of
the high incidence of radiation induced side effects.56
This is in concurrence with Rajshekhar et al. who in
2016 in a retrospective cohort study stated that a
marginal dose of 15 Gy resulted in an obliteration
rate of 66.7%.57 A univariate and multivariate
analysis was done by Reyns et al. in 2007 in which
they reviewed data from 100 children and suggested
that radiosurgery is a safe method.58
However, for high grade AVM in children
the success rate of single dose SRS is limited and
other treatment options should be explored. One
option could be intensity-modulated radiosurgery
(IMRS) for treatment of complex AVM which has
favourable outcomes.7 A clinical trial done by Woo et
al. in 1996 compared SRS with IMRS and stated that
IMRS is superior to SRS for irregular shaped
AVMs.34 This is in accordance with a literature
review done by Sterzing et al in 2007. They stated
that conventional radiotherapy has been associated
with limited dose to the target and there is high risk
of damage to normal tissues.59
Complications
Complications after radio surgery include
haemorrhage, seizures, delayed cysts and other
adverse effects. Factors that determine complications
include clinical history, previous AVM surgery and
previous radiation exposure.6
During a mean post Gamma knife radio
surgery (GKRS) follow up over a period of 10.2
years, 15 (8.3%) of the 181 patients who underwent
surgery experienced stereotactic radiosurgery related
symptomatic complications. Among the 15 patients,
12 manifested complications in 5 years or more after
GKRS and in 5 of these 12 patients, complications
were seen in 10 years or more after GKRS.6
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Flickinger et al in 1998 in a multivariate analysis
study suggested that the risk of complication can be
predicted according to the PIE (post radiosurgery
injury expression) score but other factors that may
eventually lead to radiation necrosis still need to be
researched.60 Results showed that symptomatic post
radiosurgery sequelae developed in 30 (9%) of 332
patients.
Karlsson et al in 1998 suggested that risk of
complication is not dependent on age or gender.6 In a
study, published in 2005, from 201 patients who
underwent radio surgery only 12 developed post
treatment haemorrhage. Patient age was not related to
post treatment bleeding.61 This was in concordance
with the clinical study done by Karlsson et al. in
1997 that stated complication risk is not dependent
on age.6 However, Lv et al in a retrospective analysis
of a case series of 496 patients in 2016 suggested that
occurrence of subsequent haemorrhage from AVM
was associated with younger age and female
gender.62
Pollock et al in 1996 did a multi variate
analysis in which angiographic characteristics of 315
patients after radio surgery were observed. It was
found that patients who had complete obliteration did
not experience hemorrhage.63 This was also
confirmed by a univariate and multivariate analysis
done by Nataf et al in 2004 that suggested that
haemorrhage risk is increased in patients with poor
obliteration levels.5
Such was shown in a study where median
clinical follow-up was 53.8 months. 47.6% of
patients had an AVM with a Spetzler-Martin grade ≥
III. The median administered margin and maximum
doses were 22 and 40 Gy, respectively. The overall
obliteration rate was 70.5%. Of patients who showed
complete obliteration, 74.4% developed adverse
radiation effects within 4–6 months after GKRS.64
Besides haemorrhage late adverse radiation
effects (ARE) can occur after radio surgery.64 These
include lesional oedema and cyst formation.
Treatment usually involves resection of the
thrombosed AVM.51 One article suggests that these
adverse effects peak at 7–12 months.64 Late-onset
ARE (i.e., >12 months) correlated to a failure to
obliterate the nidus. 58.1% of patients who developed
appreciable AREs (defined as ARE index >8)
proceeded to have complete nidus obliteration.
Appreciable AREs were found to be influenced by
AVM nidus volume >3 ml, lobar location, number of
draining veins and feeding arteries, prior
embolization, and higher margin dose. On the other
hand, a minimum ARE index >8 predicted
obliteration (p=0.043) the study hence proved that
ARE development after radiosurgery follows a
temporal pattern peaking at 7–12 months after
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stereotactic radiosurgery and that ARE index serves
as an important tool in patient follow-up and outcome
prediction.
Cyst formation, although rare but a study
mentioned a case where 3 years after radio surgery a
24-year-old woman developed a cyst in the parietal
lobe of her brain.44 Another older article also
mentioned 2 case reports of delayed cyst formation.65
In a Retrospective review of 233 AVM
patients having SRS from 1990 to 2009. Patients had
sporadic AVM, no prior radiation, and a minimum of
5 years of magnetic resonance imaging (MRI)
follow-up. The study showed that late ARE were
observed in 16 patients (6.9%) at a median of 8.7
years after SRS (range, 2.0–16.1). The 5, 10, and 15year incidence of late ARE was 0.4%, 7.7%, and
12.5%, respectively. Eight patients (3.4%) were
symptomatic at the time of ARE detection. Three of 8
patients who were initially asymptomatic had
documented cyst progression (at 11, 40, and 42
months), for an overall symptomatic rate of 4.7%.
Five patients with asymptomatic ARE have been
observed for a median of 9.3 years (range, 2.0–14.1)
without progression. Patients having early radiation
induced changes RIC (hazard ratio [HR] = 2.11, p<
.001), patients having obliteration (HR = 1.24, p=
.02), and patients having SRS before April 1997 (HR
= 1.12, p= .02) were more likely to develop late
ARE.51 Therefore it was proved that late ARE are
common in AVM patients who develop early RIC
after SRS. Resection of the thrombosed AVM and the
adjacent damaged tissue is effective at eliminating
the mass effect and improving patients' neurological
condition.
A clinical study was done by Malikova et al
in 2016 to determine late morphological changes
after radio surgery. The study stated that Gamma
knife radiosurgery for AVM is a safe treatment
method but delayed complications cannot be avoided
and were found. Also, post-gadolinium enhancement
could be a sign of an active, delayed post-irradiative
process.66
Murray et al. in a cohort study published in
the year 2014 discussed the Neuropsychological
outcomes
of
hypo-fractionated
stereotactic
radiotherapy (HSRT) for AVM. It demonstrated that
patients had memory improvement several years later
and this form of treatment was not associated with
long-term, harmful cognitive side effects.67
Prior to HSRT treatment AVM showed
deviations from the mean of the normal population in
a number of cognitive domains measured. Five out of
nine cognitive domains were impaired especially
processing speed, learning, naming, verbal fluency,
and executive functioning were mildly impaired.
However, domains of semantic processing, memory,

http://www.jamc.ayubmed.edu.pk

J Ayub Med Coll Abbottabad 2018;30(3)

attention and visuospatial function were in normal
limits although the mean score of major cognitive
domains we’re reaching impaired levels. Mild CNS
toxicity is expected in HSRT treatment but in
contrast to above cognitive domains remained stable
during follow up assessments.67
Follow up:
The current standard for assessing obliteration after
SRS is digital subtraction angiography (DSA). As of
late MRI and MR angiography (MRA) have gained
considerable popularity. A study was done to
compare MRI with conventional angiography. The
results of the study revealed that there was no
difference in diagnosing the patency of AVM on
MRI and with conventional angiography.68
This is in contradiction to a more recent
study that was done to find out the specificity and
sensitivity of MRI/MRA. This study revealed that the
sensitivity and specificity were in the range of 70–
95% and were not that low but still DSA should be
used to confirm the obliteration rate.69

Considering the above literature, stereotactic radio
surgery seems to be a good treatment modality due to
its high obliteration rate and low complication risk. It
was considered as a good option for tumours that had
lesser volume but higher grade. Haemorrhage,
seizures, headaches and neurological deficits occur
less frequently and the complications of radio surgery
are usually because of incomplete obliteration.
However, for tumours with greater volume and larger
size a multimodal approach can be considered such
as microsurgery combined with radiosurgery,
combined embolization and radiosurgery and
intensity modulated radiotherapy. The latter being the
preferred choice in children with higher grade and
larger size of AVM.
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